Indivior Pharmaceuticals Inc
INDV
Rang in aandelen
#3858
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aandeelprijs
$34.56
Marktkapitalisatie
$4.31B
Verandering (1 dag)
2.03%
Verandering (1 jaar)
42.27%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Categorie
Healthcare
P/B-ratio voor Indivior Pharmaceuticals Inc (INDV)
P/B-ratio op October 2026 TTM: -20.59
Volgens de meest recente financiële rapporten en aandelenkoers van Indivior Pharmaceuticals Inc is de huidige P/B-ratio (TTM) -20.59. Eind 2023 had het bedrijf een P/B-ratio van 31.28.
P/B-ratiohistoriek voor Indivior Pharmaceuticals Inc van 2016 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
